HAGAN JOSEPH P (President and CEO) purchased 23.7% of their position (50K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market purchase worth $54.3K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/31/2025ACC: 0000950170-25-011853
DirectorOfficer· President and CEO
Since Feb 2019
+1.40M
Net shares
Net buyer
$54.3K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.40M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$1.09
Trade value
$54.26K
% of position
23.7%
1/30/2025
210.81K→260.81K
Total
Net shares
+50K
Net value
$54.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2025 | P · Purchase | +50K | $1.09 | $54.26K | 23.7% | 210.81K | 260.81K |
| Total | +50K | $54.26K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.35M shares
Shares
+1.35M
Strike price
1
Held after
1.35M
Exercisable
—
1/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.35M shares | 1/30/2025 | A · Award | +1.35M | 1 | — | 1.35M |